Interest Rate Concerns Send Stocks Lower 📉

[Image](www.elitetrade.club) Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. Welcome to the Closing Bell Roundup. Please, feel free to reply to this email and tell us what you think of this new addition to the Elite Trade Club lineup! It's Thursday, December 15th, and we're back with another round of the Closing Bell Roundup. I hope you had a great day! Quick reminder, don't forget to text CLOSE to 47121 or [click here]( to sign up for our closing bell mobile alert list, so you never miss another hot stock! Here's what moved the market today: Markets 📈 US benchmarks took steep losses today as investors processed Wednesday's hawkish comments from Fed chairman Jerome Powell. The S&P 500 [-2.4%], Dow [-2.2%], Nasdaq [-3.2%], and Russell 2K [-2.6%] all posted losses on the trading day. Sponsored [Breaking News Could Send this Stock Higher]( 📢 A promising growth stock could be on the verge of a breakout. This company has made a name for itself in a massive market, and a new press release could be the catalyst it needs to rally. This could be your last chance to get in ahead of a big move. [Get the Ticker & More Details Here]( Today's Market-Moving News 🔎 📉 Investors Process Fed Comments: The Federal Reserve plans to raise rates to above 5% in 2023, according to yesterday's comments from Chairman Jerome Powell. The figure was higher than investors had previously expected. Today's Top Winners and Losers 🔥 Third Harmonic Bio [THRD] $4.30 (-78.2%) Third Harmonic discontinued a Phase 1b study of THB001 after it observed serious complications in two subjects enrolled in its first dose cohort. Gorilla Technology Group [GRRR] $4.91 (-36.6%) Gorilla Technology Group announced the appointment of an 18-year industry veteran, Max Lin, as general manager of its crucial Taiwan division. Novavax [NVAX ://elitetra.de/L2Ic ] $11.32 (-34.3%) Novavax announced a proposed offering of $125 million worth of convertible senior notes due in 2027. The company also expects to grant purchasers a 30-day option to purchase up to an additional $18.75 million in aggregate principal notes. IMV [IMV] $3.64 (+66.5%) IMV announced promising initial data from a VITALIZE Phase 2B trial evaluating MVP-S in combination with pembrolizumab in certain lymphoma patients. The company will present detailed results at the Immuno-Oncology 260 conference in New York City on Feb. 7th to 10th, 2023. Champions Oncology [CSBR] $5.50 (+19.5%) Champions Oncology recovered from its Wednesday sell-off with big gains in today's trading session. Shares sold off after the company released its fiscal Q2 2023 earnings report in Tuesday's after-market, but the move may have been overdone because shares rebound sharply today. Clearmind Medicine [CMND] $4.03 (+26.7%) Clearmind Medicine rallied after its CEO Adi Zuloff-Shani issued a letter to shareholders outlining the firm's latest accomplishments and progress towards it clinical goals. The stock has been running hot since the firm announced it was prepared to submit an investigational new drug application for its CMND-100 drug for alcohol use earlier in the week. That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members! Thanks for reading. I'll see you at the next open! Best Regards, Adam G. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( alerts delivered straight to your cell every morning for free?* P.P.S... Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! You can also text CLOSE to 47121 or [click here]( to get the Closing Bell Roundup sent to your mobile inbox, too! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](